Europe organ transplant diagnostics market was valued at $ 706.4 million in 2021 and will grow by 8.6% annually over 2021-2031, driven by the growing number of transplantations & prevalence of chronic diseases, the high demand for molecular diagnostic tests, the availability of technologically advanced devices, and the surging investment and expenditure in healthcare and diagnostics.
Highlighted with 41 tables and 62 figures, this 129-page report "Europe Organ Transplant Diagnostics Market 2021-2031 by Offering (Instruments, Test Kits & Consumables, Software & Services), Transplant (Solid Organ, Stem Cell, Soft Tissue), Application (Diagnostics, Translational Research), Technology (Molecular Technologies, Serology, Flow Cytometry, Others), End User (Hospitals and Transplant Centers, Reference Laboratories, Academic and Research Institutions, Others), and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire Europe organ transplant diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter's Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe organ transplant diagnostics market in every aspect of the classification from perspectives of Offering, Transplant, Application, Technology, End User, and Country.
Based on Offering, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Instruments
- Test Kits & Consumables
o Kits & Assays
o Consumables
- Software & Services
Based on Transplant, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Solid Organ Transplant
o Kidney
o Liver
o Heart
o Lung
o Pancreas
o Kidney-Pancreas
o Other Solid Organ Transplants
- Stem Cell Transplant
- Soft Tissue Transplant
By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Diagnostics
o Donor Testing
o Recipient Testing
- Translational Research
By Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Molecular Technologies
o PCR
o Sequencing
o Other Molecular Technologies
- Serology
- Flow Cytometry
- Other Technologies
By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Hospitals and Transplant Centers
- Reference Laboratories
- Academic and Research Institutions
- Other End Users
Geographically, the following national/local markets are fully investigated:
- Germany
- UK
- France
- Spain
- Italy
- Netherlands
- Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering, Transplant and Technology over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories Inc.
ARUP Laboratories
BAG Health Care GmbH
Becton Dickinson and Company
bioM?rieux S.A.
Bio-Rad Laboratories, Inc.
CareDx, Inc.
Eurofins Scientific
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Immucor, Inc.
Laboratory Corporation of America Holdings
Novacyt Group
Omixon Ltd.
OPKO Health
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter's Fiver Forces Analysis 39
3 Segmentation of Europe Market by Offering 43
3.1 Market Overview by Offering 43
3.2 Instruments 45
3.3 Test Kits & Consumables 47
3.3.1 Kits & Assays 48
3.3.2 Consumables 50
3.4 Software & Services 52
4 Segmentation of Europe Market by Transplant 54
4.1 Market Overview by Transplant 54
4.2 Solid Organ Transplant 56
4.2.1 Kidney 58
4.2.2 Liver 59
4.2.3 Heart 60
4.2.4 Lung 61
4.2.5 Pancreas 62
4.2.6 Kidney-Pancreas 63
4.2.7 Other Solid Organ Transplants 64
4.3 Stem Cell Transplant 65
4.4 Soft Tissue Transplant 66
5 Segmentation of Europe Market by Application 67
5.1 Market Overview by Application 67
5.2 Diagnostics 69
5.2.1 Donor Testing 70
5.2.2 Recipient Testing 71
5.3 Translational Research 72
6 Segmentation of Europe Market by Technology 73
6.1 Market Overview by Technology 73
6.2 Molecular Technologies 75
6.2.1 PCR 77
6.2.2 Sequencing 78
6.2.3 Other Molecular Technologies 79
6.3 Serology 80
6.4 Flow Cytometry 81
6.5 Other Technologies 82
7 Segmentation of Europe Market by End User 83
7.1 Market Overview by End User 83
7.2 Hospitals and Transplant Centers 85
7.3 Reference Laboratories 86
7.4 Academic and Research Institutions 87
7.5 Other End Users 88
8 European Market 2021-2031 by Country 89
8.1 Overview of European Market 89
8.2 Germany 92
8.3 U.K. 94
8.4 France 96
8.5 Spain 98
8.6 Italy 100
8.7 Netherlands 102
8.8 Rest of European Market 104
9 Competitive Landscape 106
9.1 Overview of Key Vendors 106
9.2 New Product Launch, Partnership, Investment, and M&A 109
9.3 Company Profiles 110
Abbott Laboratories Inc. 110
ARUP Laboratories 112
BAG Health Care GmbH 113
Becton Dickinson and Company 114
bioM
Selected Key Players:
Abbott Laboratories Inc.
ARUP Laboratories
BAG Health Care GmbH
Becton Dickinson and Company
bioM
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)